Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
|
|
67.
|
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer. [electronic resource] by
- Andre, F
- Conforti, R
- Moeder, C B
- Mauguen, A
- Arnedos, M
- Berrada, N
- Delaloge, S
- Tomasic, G
- Spielmann, M
- Esteva, F J
- Rimm, D L
- Michiels, S
Producer: 20121119
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
68.
|
Dynamic interaction of PTPmu with multiple cadherins in vivo. [electronic resource] by
- Brady-Kalnay, S M
- Mourton, T
- Nixon, J P
- Pietz, G E
- Kinch, M
- Chen, H
- Brackenbury, R
- Rimm, D L
- Del Vecchio, R L
- Tonks, N K
Producer: 19980514
In:
The Journal of cell biology vol. 141
Availability: No items available.
|
|
69.
|
Immunological differences between primary and metastatic breast cancer. [electronic resource] by
- Szekely, B
- Bossuyt, V
- Li, X
- Wali, V B
- Patwardhan, G A
- Frederick, C
- Silber, A
- Park, T
- Harigopal, M
- Pelekanou, V
- Zhang, M
- Yan, Q
- Rimm, D L
- Bianchini, G
- Hatzis, C
- Pusztai, L
Producer: 20191113
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
70.
|
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial. [electronic resource] by
- Cheng, H
- Ballman, K
- Vassilakopoulou, M
- Dueck, A C
- Reinholz, M M
- Tenner, K
- Gralow, J
- Hudis, C
- Davidson, N E
- Fountzilas, G
- McCullough, A E
- Chen, B
- Psyrri, A
- Rimm, D L
- Perez, E A
Producer: 20141104
In:
British journal of cancer vol. 111
Availability: No items available.
|
|
71.
|
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error. [electronic resource] by
- Shipitsin, M
- Small, C
- Choudhury, S
- Giladi, E
- Friedlander, S
- Nardone, J
- Hussain, S
- Hurley, A D
- Ernst, C
- Huang, Y E
- Chang, H
- Nifong, T P
- Rimm, D L
- Dunyak, J
- Loda, M
- Berman, D M
- Blume-Jensen, P
Producer: 20141104
In:
British journal of cancer vol. 111
Availability: No items available.
|
|
72.
|
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. [electronic resource] by
- Shi, W
- Jiang, T
- Nuciforo, P
- Hatzis, C
- Holmes, E
- Harbeck, N
- Sotiriou, C
- Peña, L
- Loi, S
- Rosa, D D
- Chia, S
- Wardley, A
- Ueno, T
- Rossari, J
- Eidtmann, H
- Armour, A
- Piccart-Gebhart, M
- Rimm, D L
- Baselga, J
- Pusztai, L
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 10 2018
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
73.
|
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. [electronic resource] by
- Shi, W
- Jiang, T
- Nuciforo, P
- Hatzis, C
- Holmes, E
- Harbeck, N
- Sotiriou, C
- Peña, L
- Loi, S
- Rosa, D D
- Chia, S
- Wardley, A
- Ueno, T
- Rossari, J
- Eidtmann, H
- Armour, A
- Piccart-Gebhart, M
- Rimm, D L
- Baselga, J
- Pusztai, L
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 06 2019
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
74.
|
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. [electronic resource] by
- Shi, W
- Jiang, T
- Nuciforo, P
- Hatzis, C
- Holmes, E
- Harbeck, N
- Sotiriou, C
- Peña, L
- Loi, S
- Rosa, D D
- Chia, S
- Wardley, A
- Ueno, T
- Rossari, J
- Eidtmann, H
- Armour, A
- Piccart-Gebhart, M
- Rimm, D L
- Baselga, J
- Pusztai, L
Producer: 20180501
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
75.
|
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers. [electronic resource] by
- Gettinger, S N
- Choi, J
- Mani, N
- Sanmamed, M F
- Datar, I
- Sowell, Ryan
- Du, Victor Y
- Kaftan, E
- Goldberg, S
- Dong, W
- Zelterman, D
- Politi, K
- Kavathas, P
- Kaech, S
- Yu, X
- Zhao, H
- Schlessinger, J
- Lifton, R
- Rimm, D L
- Chen, L
- Herbst, R S
- Schalper, K A
Producer: 20181226
In:
Nature communications vol. 9
Availability: No items available.
|
|
76.
|
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. [electronic resource] by
- Salgado, R
- Denkert, C
- Demaria, S
- Sirtaine, N
- Klauschen, F
- Pruneri, G
- Wienert, S
- Van den Eynden, G
- Baehner, F L
- Penault-Llorca, F
- Perez, E A
- Thompson, E A
- Symmans, W F
- Richardson, A L
- Brock, J
- Criscitiello, C
- Bailey, H
- Ignatiadis, M
- Floris, G
- Sparano, J
- Kos, Z
- Nielsen, T
- Rimm, D L
- Allison, K H
- Reis-Filho, J S
- Loibl, S
- Sotiriou, C
- Viale, G
- Badve, S
- Adams, S
- Willard-Gallo, K
- Loi, S
Producer: 20160224
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|